ATE424824T1 - Verfahren zur verhütung oder behandlung von herzarrhythmie - Google Patents

Verfahren zur verhütung oder behandlung von herzarrhythmie

Info

Publication number
ATE424824T1
ATE424824T1 AT03713563T AT03713563T ATE424824T1 AT E424824 T1 ATE424824 T1 AT E424824T1 AT 03713563 T AT03713563 T AT 03713563T AT 03713563 T AT03713563 T AT 03713563T AT E424824 T1 ATE424824 T1 AT E424824T1
Authority
AT
Austria
Prior art keywords
preventing
treating cardiac
arhythmia
cardiac arhythmia
vanoxerine
Prior art date
Application number
AT03713563T
Other languages
English (en)
Inventor
Arthur M Brown
Original Assignee
Chantest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chantest Inc filed Critical Chantest Inc
Application granted granted Critical
Publication of ATE424824T1 publication Critical patent/ATE424824T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03713563T 2002-02-22 2003-02-21 Verfahren zur verhütung oder behandlung von herzarrhythmie ATE424824T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/079,485 US6743797B2 (en) 2002-02-22 2002-02-22 Methods for treating cardiac arrhythmia

Publications (1)

Publication Number Publication Date
ATE424824T1 true ATE424824T1 (de) 2009-03-15

Family

ID=27752750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03713563T ATE424824T1 (de) 2002-02-22 2003-02-21 Verfahren zur verhütung oder behandlung von herzarrhythmie

Country Status (9)

Country Link
US (5) US6743797B2 (de)
EP (2) EP1485096B1 (de)
JP (1) JP4565841B2 (de)
AT (1) ATE424824T1 (de)
AU (1) AU2003217607B2 (de)
CA (2) CA2696267A1 (de)
DE (1) DE60326548D1 (de)
NZ (1) NZ535334A (de)
WO (1) WO2003072030A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
JP2007534300A (ja) * 2003-07-15 2007-11-29 チャンエクスプレス インコーポレイテッド 内在性膜タンパク質の表面発現を変える薬剤を特定するためのハイスループットアッセイシステムおよび方法
US20090143434A1 (en) * 2007-12-03 2009-06-04 Brown Arthur M Methods of using domperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm or heart rate, to prevent recurrence of cardiac arrhythmia and to maintain normal sinus rhythm or heart rate in mammals
US20120010216A1 (en) * 2010-07-06 2012-01-12 Brown Arthur M Pharmaceutical compositions containing vanoxerine
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
US20150336917A1 (en) * 2012-10-11 2015-11-26 Laguna Pharmaceuticals, Inc. Novel piperazine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals
US20150283131A1 (en) * 2012-10-11 2015-10-08 Chanrx Corporation Pharmaceutical compositions containing piperazine compounds in combination with a p450 inhibitor and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions
WO2014059367A1 (en) * 2012-10-11 2014-04-17 Chanrx Corporation Pharmaceutical compositions containing enantiomerically pure and/or racemic mixtures of chiral piperazine compounds and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions
WO2014176557A2 (en) * 2013-04-26 2014-10-30 Chanrx Corporation Methods for calibrating the administration of vanoxerine for terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythm in mammals
WO2014176497A1 (en) * 2013-04-26 2014-10-30 Chanrx Corporation Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals
US20160303114A1 (en) * 2013-04-26 2016-10-20 Laguna Pharmaceuticals, Inc. Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythym in mammals through administration of said compositions
WO2015119938A1 (en) * 2014-02-05 2015-08-13 Chanrx Corporation Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia, and/or maintaining normal sinus rhythm in mammals
KR101617683B1 (ko) 2015-01-09 2016-05-03 연세대학교 산학협력단 부정맥 치료제 효과 평가 시스템 및 방법
WO2019147889A1 (en) * 2018-01-26 2019-08-01 Brown Arthur M Compositions and methods for treating atrial fibrillation and/or atrial flutter in a human
WO2019147890A1 (en) * 2018-01-26 2019-08-01 Brown Arthur M Compositions and methods for preventing the recurrence of atrial fibrillation and/or atrial flutter in a human
CN111329860A (zh) * 2019-03-01 2020-06-26 杭州健石药业有限公司 Vanoxerine在持续性房颤的药中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives
NL8202636A (nl) 1982-06-29 1984-01-16 Gist Brocades Nv Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
HU196194B (en) 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
WO1991001732A1 (en) 1989-08-03 1991-02-21 The United States Of America, Represented By The Secretary, United States Department Of Commerce Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists
DE19547263C2 (de) * 1995-12-07 1999-04-29 Cardiotec Inc Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB9705428D0 (en) 1997-03-15 1997-04-30 Knoll Ag Therapeutic agents
WO1999059594A1 (en) * 1998-05-15 1999-11-25 Merck & Co., Inc. Potassium channel agonists
ATE387222T1 (de) * 2000-07-14 2008-03-15 Merck & Co Inc Radioliganden- und bindungs-assay
EP1324780A4 (de) 2000-09-06 2005-06-22 Univ Johns Hopkins Methoden zur behandlung von herzarrhythmie
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia

Also Published As

Publication number Publication date
EP1485096A2 (de) 2004-12-15
US20100069403A1 (en) 2010-03-18
DE60326548D1 (de) 2009-04-23
AU2003217607B2 (en) 2008-08-14
US20080214554A1 (en) 2008-09-04
AU2003217607A1 (en) 2003-09-09
WO2003072030A2 (en) 2003-09-04
US20030162793A1 (en) 2003-08-28
EP2052722A1 (de) 2009-04-29
US8450325B2 (en) 2013-05-28
US20110237604A1 (en) 2011-09-29
CA2696267A1 (en) 2003-09-04
US20040138146A1 (en) 2004-07-15
EP1485096A4 (de) 2007-07-11
CA2476996A1 (en) 2003-09-04
WO2003072030A3 (en) 2004-01-22
JP2005524646A (ja) 2005-08-18
JP4565841B2 (ja) 2010-10-20
NZ535334A (en) 2006-04-28
US7700600B2 (en) 2010-04-20
EP1485096B1 (de) 2009-03-11
CA2476996C (en) 2011-02-15
US6743797B2 (en) 2004-06-01

Similar Documents

Publication Publication Date Title
DE60326548D1 (de) Verfahren zur verhütung oder behandlung von herzarrhythmie
ATE517632T1 (de) Niedrigdosierte verfahren zur behandlung von erkrankungen, bei denen tnf-alpha-aktivität schädlich ist
CY1120977T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
ATE499934T1 (de) Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
DE602004017481D1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
BR0308813A (pt) Tratamento de tuberculose usando derivados de pleuromutilina
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
RU94044490A (ru) Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
EP1499190A4 (de) Verfahren zur behandlung von lebererkrankungen und leberschäden mit wachstumshormon und foxm1b
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE250936T1 (de) Verfahren zur behandlung von erkrankungen oder störungen des innenohrs
CA2585266A1 (en) Ophthalmic compositions and methods of using the same
ATE516040T1 (de) Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis
ATE257384T1 (de) Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties